Rieger Jayson
CEO and President
Rieger Jayson has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Rieger Jayson is listed as CEO and President at Verrica Pharmaceuticals Inc. Inside the rolling window, Rieger Jayson reported 3 open-market purchases totaling $526K in VRCA and no open-market sales. The largest disclosed transaction in the window is a purchase of 94,311 VRCA shares on Nov 25, 2025, worth $400K.
Companies traded
Other insiders at VRCA
Insider Buying
$526K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rieger Jayson made?
Rieger Jayson has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Rieger Jayson trade?
Rieger Jayson has filed SEC Form 4 disclosures for 1 company, including VRCA.
When was Rieger Jayson's most recent SEC Form 4 filing?
Rieger Jayson's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Rieger Jayson's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rieger Jayson is listed as CEO and President.
What is Rieger Jayson's total buy and sell value in the current window?
Inside the rolling retention window, Rieger Jayson bought $526K and sold $0 based on SEC Form 4 filings.
What was Rieger Jayson's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 94,311 VRCA shares on 2025-11-25, worth $400K, per SEC Form 4 filings.